Increase in Prices for Brand-Name Drugs Under Part D
Prices for the most commonly used brand-name drugs have risen substantially since 2002.� For example, prices for the most commonly used brand-name drugs increased nearly 13 percent in 2013; this increase was 8 times greater than the general inflation rate for the same year.� We will evaluate the extent to which pharmacy reimbursement for brand-name drugs under Medicare Part�D changed between 2011 and 2015 and compare the rate of change in pharmacy reimbursement for brand-name drugs under Medicare Part D to the rate of inflation for the same period.
Announced or Revised | Agency | Title | Component | Report Number(s) | Expected Issue Date (FY) |
---|---|---|---|---|---|
Completed | Centers for Medicare & Medicaid Services | Increase in Prices for Brand-Name Drugs Under Part D | Office of Evaluation and Inspections | OEI-03-15-00080 | 2018 |